US Stock MarketDetailed Quotes

MINDMAZE THERAPEUTICS HOLDING SA SPON ADS EACH REP 1 ORD SHS (RLFTY)

Watchlist
  • 0.4225
  • 0.00000.00%
15min DelayTrading Jun 1 11:16 ET
64.47MMarket Cap-0.69P/E (TTM)

MINDMAZE THERAPEUTICS HOLDING SA SPON ADS EACH REP 1 ORD SHS (RLFTY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
Total revenue
642K
0
Operating revenue
--642K
--0
Cost of revenue
51K
0
Gross profit
591K
0
Operating expense
555,200.00%11.11M
2K
Selling and administrative expenses
290,750.00%5.82M
--2K
-Selling and marketing expense
--1.2M
--0
-General and administrative expense
230,800.00%4.62M
--2K
Research and development costs
--5.29M
--0
Depreciation amortization depletion
----
--2.56M
-Depreciation and amortization
----
--2.56M
Operating profit
-525,650.00%-10.52M
-2K
Net non-operating interest income expense
3,000.00%31K
1K
Non-operating interest income
31,100.00%312K
--1K
Non-operating interest expense
--266K
--0
Total other finance cost
-71.15%15K
--52K
Other net income (expense)
-11.37M
Gain on sale of security
----
---87K
Special income (charges)
----
---11.5M
-Less:Restructuring and merger&acquisition
----
---4.5M
-Less:Impairment of capital assets
----
--16.83M
-Less:Other special charges
----
--305K
-Write off
----
---237K
-Gain on sale of property,plant,equipment
----
--899K
Other non- operating income (expenses)
----
--220K
Income before tax
-990,500.00%-9.91M
-1K
Income tax
0
0
Net income
-990,500.00%-9.91M
-1K
Net income continuous Operations
-990,500.00%-9.91M
---1K
Minority interest income
Net income attributable to the parent company
-990,500.00%-9.91M
-1K
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-990,500.00%-9.91M
-1K
Basic earnings per share
-0.48
0
Diluted earnings per share
-0.48
0
Dividend per share
Currency Unit
CHF
CHF
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
(FY)Dec 31, 2025(FY)Dec 31, 2024
Total revenue 642K0
Operating revenue --642K--0
Cost of revenue 51K0
Gross profit 591K0
Operating expense 555,200.00%11.11M2K
Selling and administrative expenses 290,750.00%5.82M--2K
-Selling and marketing expense --1.2M--0
-General and administrative expense 230,800.00%4.62M--2K
Research and development costs --5.29M--0
Depreciation amortization depletion ------2.56M
-Depreciation and amortization ------2.56M
Operating profit -525,650.00%-10.52M-2K
Net non-operating interest income expense 3,000.00%31K1K
Non-operating interest income 31,100.00%312K--1K
Non-operating interest expense --266K--0
Total other finance cost -71.15%15K--52K
Other net income (expense) -11.37M
Gain on sale of security -------87K
Special income (charges) -------11.5M
-Less:Restructuring and merger&acquisition -------4.5M
-Less:Impairment of capital assets ------16.83M
-Less:Other special charges ------305K
-Write off -------237K
-Gain on sale of property,plant,equipment ------899K
Other non- operating income (expenses) ------220K
Income before tax -990,500.00%-9.91M-1K
Income tax 00
Net income -990,500.00%-9.91M-1K
Net income continuous Operations -990,500.00%-9.91M---1K
Minority interest income
Net income attributable to the parent company -990,500.00%-9.91M-1K
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -990,500.00%-9.91M-1K
Basic earnings per share -0.480
Diluted earnings per share -0.480
Dividend per share
Currency Unit CHFCHF
Audit Opinions --Unqualified Opinion with Explanatory Notes
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 1 Eastern Time, Middle East geopolitics took a dramatic turn. Iran's Tasnim News Agency reported that, in light of Israel’s ongoing Show More